blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0316723

EP0316723 - 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.08.1993
Database last updated on 15.06.2024
Most recent event   Tooltip03.08.1993No opposition filed within time limitpublished on 22.09.1993 [1993/38]
Applicant(s)For all designated states
HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
Route 202-206 North Somerville
New Jersey 08876 / US
[N/P]
Former [1989/21]For all designated states
HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
Route 202-206 North
Somerville New Jersey 08876 / US
Inventor(s)01 / Hrib, Nicholas J.
356 Gemini Drive, Apt. 4
Somerville, N.J. 08876 / US
02 / Jurcak, John Gerard
70 JFK Boulevard, Apt. 315
Somerset, N.J. 08873 / US
[1992/40]
Former [1989/21]01 / Hrib, Nicholas J.
356 Gemini Drive Apt. 4
Somerville, N.J. 08876 / US
02 / Jurcak, John Gerard
70 JFK Boulevard Apt. 315
Somerset, N.J. 08873 / US
Representative(s)Becker, Heinrich Karl Engelbert, et al
HOECHST AKTIENGESELLSCHAFT Zentrale Patentabteilung Gebäude F 821
65926 Frankfurt am Main / DE
[N/P]
Former [1989/21]Becker, Heinrich Karl Engelbert, Dr., et al
HOECHST AKTIENGESELLSCHAFT Zentrale Patentabteilung Gebäude F 821
D-65926 Frankfurt am Main / DE
Application number, filing date88118614.209.11.1988
[1989/21]
Priority number, dateUS1987012362220.11.1987         Original published format: US 123622
[1989/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0316723
Date:24.05.1989
Language:EN
[1989/21]
Type: B1 Patent specification 
No.:EP0316723
Date:30.09.1992
Language:EN
[1992/40]
Search report(s)(Supplementary) European search report - dispatched on:EP21.03.1989
ClassificationIPC:C07D277/14, C07D277/60, C07D417/12, C07D277/82, A61K31/425, A61K31/495
[1989/21]
CPC:
C07D277/60 (EP,US); C07D401/06 (KR); A61K31/44 (KR);
A61P25/04 (EP); A61P25/08 (EP); A61P25/18 (EP);
A61P25/20 (EP); A61P25/24 (EP); A61P25/26 (EP);
C07D277/14 (EP,KR,US); C07D277/82 (EP,US); C07D417/12 (EP,US);
C07D417/14 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/21]
TitleGerman:3-[4(1-Substituierte-4-Piperazinyl)butyl]-4-Thiazolidinone, Verfahren zu deren Herstellung und ihre Anwendung als Arzneimittel[1989/21]
English:3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments[1989/21]
French:3-[4(1-substitué-4-pipérazinyl)butyl]-4-thiazolidinones procédé de préparation et leur utilisation comme médicaments[1989/21]
Examination procedure27.07.1989Examination requested  [1989/38]
27.03.1991Despatch of a communication from the examining division (Time limit: M04)
02.08.1991Reply to a communication from the examining division
20.08.1991Despatch of a communication from the examining division (Time limit: M04)
20.12.1991Reply to a communication from the examining division
19.03.1992Despatch of communication of intention to grant (Approval: Yes)
02.04.1992Communication of intention to grant the patent
11.06.1992Fee for grant paid
11.06.1992Fee for publishing/printing paid
Opposition(s)01.07.1993No opposition filed within time limit [1993/38]
Fees paidRenewal fee
12.10.1990Renewal fee patent year 03
21.12.1990Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2520179  (SURREY ALEXANDER R);
 [A]FR2510571  (BRISTOL MYERS CO [US]);
 [A]DE3247530  (BRISTOL MYERS CO [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.